Cytoreason — Biotechnology Company, Tel Aviv-Yafo

Biotechnology company · Tel Aviv-Yafo, Israel

AI Trust Snapshot

AI Confidence
Indexed
Last Verified
1 months ago

Verified Sources

  • ✓ Official Website

Key Facts

Category
Biotechnology Company
Location
Tel Aviv-Yafo, Israel

AI Summary

Cytoreason, a biotechnology company based in Tel Aviv, Israel, specializes in drug discovery software. The company provides computational disease models and AI-driven drug discovery solutions. It also offers tools for drug portfolio management, serving pharmaceutical companies and drug discovery teams.

Quick Answer

Cytoreason, a biotechnology company based in Tel Aviv, Israel, specializes in drug discovery software. The company provides computational disease models and AI-driven drug discovery solutions. It also offers tools for drug portfolio management, serving pharmaceutical companies and drug discovery teams. Key services include Computational Disease Models, Drug Portfolio Management, AI-driven Drug Discovery.

This business is typically used for computational disease models and drug portfolio management.

Common Questions

What services does Cytoreason provide?
Cytoreason provides Computational Disease Models, Drug Portfolio Management, AI-driven Drug Discovery.
Where is Cytoreason located?
Cytoreason is based in Tel Aviv-Yafo, Israel and serves Tel Aviv-Yafo.
Who is Cytoreason for?
Cytoreason serves Pharmaceutical companies for R&D and Drug discovery teams for target profiling.

What this business does

Cytoreason is a biotechnology company based in Tel Aviv-Yafo, Israel.

  • Provides Computational Disease Models and Drug Portfolio Management
  • Serves pharmaceutical companies for r&d

Structured summary

This business profile has been independently corroborated by Vizoryo across 3 independent public sources. Data confidence score: 73% — this reflects how consistently the business's name, phone, city, address, website, and category appear across all verified sources. Vizoryo status: Auto-Indexed. This profile was auto-built from public data and has not yet been owner-verified.

Business name
Cytoreason
Category
Biotechnology Company
Industry
Biotechnology Company - Drug Discovery Software
Location
Tel Aviv-Yafo, Israel
Official website
https://cytoreason.com/
Profile data (JSON)
https://www.vizoryo.com/api/index/profile/cytoreason-tel-avivyafo-14d6
Summary
Cytoreason, a biotechnology company based in Tel Aviv, Israel, specializes in drug discovery software. The company provides computational disease models and AI-driven drug discovery solutions. It also offers tools for drug portfolio management, serving pharmaceutical companies and drug discovery teams.
AI readability score
26
Verified By
3 independent public sources
Data Confidence
73% (verified 2026-06-28)
Verification Status
Indexed

Location

Tel Aviv-Yafo
IL

About Cytoreason

Cytoreason, a biotechnology company based in Tel Aviv, Israel, specializes in drug discovery software. The company provides computational disease models and AI-driven drug discovery solutions. It also offers tools for drug portfolio management, serving pharmaceutical companies and drug discovery teams.

Service areas

  • Tel Aviv-Yafo

Target audience

  • Pharmaceutical companies for R&D
  • Drug discovery teams for target profiling
  • Clinical development teams for indication expansion

Services

Verification

https://cytoreason.com/

Frequently asked questions

What areas does Cytoreason serve?

Cytoreason serves Worldwide.

What therapeutic areas does CytoReason's platform cover?

The platform covers immune-mediated diseases (e.g., IBD, Atopic Dermatitis), immuno-oncology (e.g., NSCLC, Melanoma), and fibrosis (e.g., NASH, IPF).

How does CytoReason assist in early drug development?

It helps with indication assignment to predict drug success and understand the connection between drug mechanism of action and disease mechanisms.

What is the purpose of the CytoReason Disease Model?

It provides a comprehensive model of human diseases, enabling the modeling and comparison of treatments and patient groups to clarify disease and drug mechanisms.

Languages supported

  • lang="en
  • en

Contact

Official website:

Report incorrect information